Transforming early screening
Diabetic Peripheral Neuropathy (DPN) often develops silently, leading to undetected loss of sensation, autonomic dysfunction, and eventual ulceration.
Traditional physical tests, such as monofilaments or tuning forks, primarily identify damage that has already occurred. Our screening technologies detect functional sudomotor changes at an early stage, allowing clinical intervention long before skin integrity is compromised.
We operate in full alignment with international healthcare standards, maintaining strict quality assurance across all software systems, medical devices, and dermatological formulations.